|
|
| Drs. Yancy and Russo Discuss the NAPA Trial and the Use of Vasoactive Agents in Heart Failure |
Dr. Mark Russo and Dr. Clyde Yancy discuss the use of vasoactive agents in cardiovascular
disease at ACC 2007.
Dr. Mark Russo focuses on The NAPA Trial results, while Dr. Clyde Yancy talks about the
safety and efficacy of therapies for acute decompensated heart failure.
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|